The new 300µL interlocked robotic arm machine (RAM) vial with 9mm thread finish from J G Finneran Associates based in Vineland, NJ, US is aimed at researchers tasked with managing a high number of chromatography sample vials in their laboratories.
Composed of a clear or amber Type I borosilicate glass, the vial and insert are fused together keeping the insert permanently in place. This enables accurate automated injection and eliminates contamination risk around the seam or space between the neck of the vial and the insert. The interlocked RAM vial arrives ready to use saving valuable time in the laboratory.
The vial has been designed to work in robotic arm autosamplers such as those available from Agilent Technologies and others. Robotic arms can easily grasp the 12mm x 32mm outer dimensions of the vial. Chromatography samples are contained in a clear Type I borosilicate glass 300µL conical tip insert. The interlocked RAM vial includes a marking spot, which can be written on with a #2 pencil. The vial is also available with a 9mm screw thread closure.
Interlocked RAM vial provides safe sample containment
For researchers managing a high number of chromatography sample vials
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Read moreHans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Trending Articles
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe
After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region